Amwell vs Health Catalyst
Health Catalyst reported revenue of $311 million in fiscal 2025, 1.2 times Amwell's $249 million in fiscal 2025. Amwell's revenue fell 2.0% in its latest year, and Health Catalyst's grew 1.5%. Amwell had an operating margin of -42.2%, against -51.7% at Health Catalyst. Free cash flow was −$66 million at Amwell and −$0 million at Health Catalyst.
Side by side
| Amwell | Health Catalyst | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $249M | $311M |
| Revenue growth | −2.0% | 1.5% |
| Revenue growth a year, last 5 years | 0.3% | 10.5% |
| Gross margin | — | — |
| Operating margin | −42.2% | −51.7% |
| Net margin | −38.4% | −57.2% |
| Free cash flow | −$66M | −$0M |
| Free cash flow margin | −26.5% | −0.1% |
| Return on capital | — | −38.6% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $5M |
| Change in diluted share count | 7.0% | 16.1% |
| Last close | $10.69 | $1.29 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $4,938, sold $792,528 | bought $105,610, sold $200,554 |
| Piotroski F-score | — | 4 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AmwellHealth Catalyst
Operating margin
Percent of revenue
AmwellHealth Catalyst
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AmwellHealth Catalyst
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Amwell and Health Catalyst pages.